{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:51:58Z","timestamp":1709265118656},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10517-024-06023-0","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T03:04:08Z","timestamp":1707707048000},"page":"354-358","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen)"],"prefix":"10.1007","volume":"176","author":[{"given":"K. G.","family":"Starkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. V.","family":"Dolgikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. N.","family":"Alikina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. A.","family":"Kazakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Nikonoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. B.","family":"Alekseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"6023_CR1","doi-asserted-by":"publisher","unstructured":"Zolnikova OYu, Svistunov AA, Ivashkin VT. SARS-CoV-2: immune response, structural changes, treatment strategies. Ekol. Chel. 2021;(1):4-10. Russian. doi: https:\/\/doi.org\/10.33396\/1728-0869-2021-1-4-10","DOI":"10.33396\/1728-0869-2021-1-4-10"},{"key":"6023_CR2","doi-asserted-by":"publisher","unstructured":"Yokota Sh, Kuroiwa Y, Nishioka N. Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective. Infekts. Bolezni: Novosti Mneniya Obuch. 2020;9(4):13-25. Russian. doi: https:\/\/doi.org\/10.33029\/2305-3496-2020-9-4-13-25","DOI":"10.33029\/2305-3496-2020-9-4-13-25"},{"key":"6023_CR3","unstructured":"Kostiuk SA, Simirski VV, Gorbich YL, Anisko LA, Poluyan OS. Cytokine storm at COVID-19. Mezhdunarod. Obzory Klin. Praktika Zdor. 2021;(1):41-52. Russian."},{"key":"6023_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137:155323. doi: https:\/\/doi.org\/10.1016\/j.cyto.2020.155323","journal-title":"Cytokine."},{"key":"6023_CR5","doi-asserted-by":"publisher","unstructured":"Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, G\u00f3es-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. doi: https:\/\/doi.org\/10.3390\/v13040700","DOI":"10.3390\/v13040700"},{"key":"6023_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","volume":"314","author":"MP N\u00e4gele","year":"2020","unstructured":"N\u00e4gele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58-62. doi: https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.10.014","journal-title":"Atherosclerosis."},{"issue":"1","key":"6023_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","volume":"5","author":"Y Jin","year":"2020","unstructured":"Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct. Target Ther. 2020;5(1):293. doi: https:\/\/doi.org\/10.1038\/s41392-020-00454-7","journal-title":"Signal Transduct. Target Ther."},{"key":"6023_CR8","doi-asserted-by":"publisher","unstructured":"Dolgikh OV, Starkova KG, Krivtcov AV, Chelakova YuA, Chigvintsev VM, Alikina IN, Lanin DV. Modeling of combined effects of the exposure to chemicals (aluminum) and regulatory immune and endocrine factors in research on cytokines production in experiments in vitro. Gigiena Sanitariya. 2019;98(2):214-218. Russian. doi: https:\/\/doi.org\/10.18821\/0016-9900-2019-98-2-214-218","DOI":"10.18821\/0016-9900-2019-98-2-214-218"},{"key":"6023_CR9","doi-asserted-by":"publisher","unstructured":"Abakushina EV. Immunological aspects of coronavirus disease caused by SARS-CoV-2. Geny Kletki. 2020;15(3):14-21. Russian. doi: https:\/\/doi.org\/10.23868\/202011002","DOI":"10.23868\/202011002"},{"key":"6023_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75. doi: https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"6023_CR11","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130(5):2620-2629. doi: https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J. Clin. Invest."},{"key":"6023_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.21668\/health.risk\/2022.4.14.eng","volume":"4","author":"VF Sadykov","year":"2022","unstructured":"Sadykov VF, Poltavtseva RA, Chaplygina AV, Bobkova NV. Immune status and cytokine spectrum as predictors of the risk of severe disease and performance indicators of intensive therapy in patients with coronavirus infection COVID-19. Health Risk Analysis. 2022;(4):148-158. doi: https:\/\/doi.org\/10.21668\/health.risk\/2022.4.14.eng","journal-title":"Health Risk Analysis."},{"issue":"3","key":"6023_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00011-022-01543-9","volume":"71","author":"S Zivancevic-Simonovic","year":"2022","unstructured":"Zivancevic-Simonovic S, Jovanovic D, Cupurdija V, Milosevic-Djordjevic O, Stanojevic M, Marinkovic M, Igrutinovic N, Stanojevic I, Vojvodic D, Mihaljevic O. Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation. Inflamm. Res. 2022;71(3):331-341. doi: https:\/\/doi.org\/10.1007\/s00011-022-01543-9","journal-title":"Inflamm. Res."},{"issue":"17","key":"6023_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140329","volume":"5","author":"KE Remy","year":"2020","unstructured":"Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, Blood TM, Mudd PA, Yi DJ, Mannion DA, Osborne DF, Martin RS, Anand NJ, Bosanquet JP, Blood J, Drewry AM, Caldwell CC, Turnbull IR, Brakenridge SC, Moldwawer LL, Hotchkiss RS. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5(17):e140329. doi: https:\/\/doi.org\/10.1172\/jci.insight.140329","journal-title":"JCI Insight."},{"issue":"1","key":"6023_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93(1):250-256. doi: https:\/\/doi.org\/10.1002\/jmv.26232","journal-title":"J. Med. Virol."},{"key":"6023_CR16","doi-asserted-by":"publisher","unstructured":"de Morais Batista F, Puga MAM, da Silva PV, Oliveira R, Dos Santos PCP, da Silva BO, Tatara MB, Tsuha DH, Dos Santos Pires MA, Gon\u00e7alves CCM, Pessoa E Silva R, Ferreira NT, de Barros Albuquerque AP, da Silva Duarte G, Consolaro MEL, Negr\u00e3o FJ, Ferrari IC, de Goes Cavalcanti LP, Trinta KS, Ribeiro GS, de Melo R\u00eago MJB, Boyton RJ, Siqueira AM, Altmann DM, Croda J. Serum biomarkers associated with SARS-CoV-2 severity. Sci. Rep. 2022;12(1):15999. doi: https:\/\/doi.org\/10.1038\/s41598-022-20062-5","DOI":"10.1038\/s41598-022-20062-5"},{"issue":"9","key":"6023_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0735-1097(22)03054-6","volume":"79","author":"J Solorzano","year":"2022","unstructured":"Solorzano J, Jaisingh K, Ahmad J, Thevuthasan S, Foster A, Watts M, Kolluru GK, Orr AW, Kevil CG, Dominic P. Vascular endothelial growth factor is associated with severe COVID-19 disease. J. Am. Coll. Cardiol. 2022;79(9):2063. doi: https:\/\/doi.org\/10.1016\/S0735-1097(22)03054-6.","journal-title":"J. Am. Coll. Cardiol."},{"key":"6023_CR18","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3604987","author":"M Turkia","year":"2020","unstructured":"Turkia M. COVID-19, vascular endothelial growth factor (VEGF) and iodide. SSRN Electronic Journal. 2020. doi: https:\/\/doi.org\/10.2139\/ssrn.3604987","journal-title":"SSRN Electronic Journal."},{"issue":"4","key":"6023_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pulmoe.2021.08.004","volume":"29","author":"G Madureira","year":"2023","unstructured":"Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology. 2023;29(4):323-331. doi: https:\/\/doi.org\/10.1016\/j.pulmoe.2021.08.004","journal-title":"A narrative review. Pulmonology."},{"issue":"Pt B","key":"6023_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108257","volume":"101","author":"A Sahebnasagh","year":"2021","unstructured":"Sahebnasagh A, Nabavi SM, Kashani HRK, Abdollahian S, Habtemariam S, Rezabakhsh A. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. Int. Immunopharmacol. 2021;101(Pt B):108257. doi: https:\/\/doi.org\/10.1016\/j.intimp.2021.108257","journal-title":"Int. Immunopharmacol."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-024-06023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-024-06023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-024-06023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T02:09:55Z","timestamp":1708481395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-024-06023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6023"],"URL":"https:\/\/doi.org\/10.1007\/s10517-024-06023-0","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}